​There is great promise in the potential of genetic information to help inform clinicians’ decisions of which medications to prescribe. Researchers have come to believe that genetic variation may contribute to the risk/benefit ratio each drug has, and though the contribution needs to be better understood, current pharmacogenetic testing methods are robust enough to make a difference today.